**Core Concept**
Osteogenesis imperfecta (OI) is a genetic disorder characterized by fragile bones, skeletal deformities, and other systemic manifestations. It is primarily caused by mutations in the COL1A1 and COL1A2 genes, which encode the alpha-1 and alpha-2 chains of type I collagen, a crucial protein in bone formation.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of OI, which involves the defective production of type I collagen. Type I collagen is essential for giving bones their strength and structure. Mutations in the COL1A1 and COL1A2 genes lead to the production of abnormal type I collagen, resulting in fragile bones and an increased risk of fractures. This is because the abnormal collagen is less stable and more prone to degradation.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because OI is not primarily caused by mutations in the COL3A1 gene, which encodes the alpha-1 chain of type III collagen. While type III collagen is also important for connective tissue, its mutation is associated with another condition called Ehlers-Danlos syndrome.
* **Option B:** This option is incorrect because OI is not primarily caused by mutations in the COL2A1 gene, which encodes the alpha-1 chain of type II collagen. Type II collagen is primarily found in cartilage, and its mutation is associated with conditions such as spondyloepiphyseal dysplasia.
* **Option D:** This option is incorrect because OI is not primarily caused by mutations in the COL5A1 gene, which encodes the alpha-1 chain of type V collagen. While type V collagen is also important for connective tissue, its mutation is associated with conditions such as osteogenesis imperfecta type V, which has distinct clinical features.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that OI is a heterogeneous disorder with varying clinical manifestations, ranging from mild to severe. The severity of the condition is often correlated with the extent of the collagen mutation, with more severe mutations leading to more pronounced symptoms.

**Correct Answer:** C.